Drug metabolism by tumours: its nature, relevance and therapeutic implications.
about
Tumoral expression of drug and xenobiotic metabolizing enzymes in breast cancer patients of different ethnicities with implications to personalized medicine.Severely Impaired and Dysregulated Cytochrome P450 Expression and Activities in Hepatocellular Carcinoma: Implications for Personalized Treatment in Patients.CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinomaToward a new age of cellular pharmacokinetics in drug discovery.CYP3A4-dependent cellular response does not relate to CYP3A4-catalysed metabolites of C-1748 and C-1305 acridine antitumor agents in HepG2 cells.Mechanisms of Drug Resistance in Veterinary Oncology- A Review with an Emphasis on Canine Lymphoma.
P2860
Drug metabolism by tumours: its nature, relevance and therapeutic implications.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Drug metabolism by tumours: its nature, relevance and therapeutic implications.
@en
Drug metabolism by tumours: its nature, relevance and therapeutic implications.
@nl
type
label
Drug metabolism by tumours: its nature, relevance and therapeutic implications.
@en
Drug metabolism by tumours: its nature, relevance and therapeutic implications.
@nl
prefLabel
Drug metabolism by tumours: its nature, relevance and therapeutic implications.
@en
Drug metabolism by tumours: its nature, relevance and therapeutic implications.
@nl
P2860
P356
P1476
Drug metabolism by tumours: its nature, relevance and therapeutic implications.
@en
P2093
Margaret M Doherty
Michael Michael
P2860
P304
P356
10.1517/17425255.3.6.783
P407
P577
2007-12-01T00:00:00Z